Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate XOMA Royalty Corporation before investing.

In this article, we go over a few key elements for understanding XOMA Royalty Corporation’s stock price such as:

• XOMA Royalty Corporation’s current stock price and volume
• Why XOMA Royalty Corporation’s stock price changed recently
• Upgrades and downgrades for XOMA from analysts
• XOMA’s stock price momentum as measured by its relative strength

About XOMA Royalty Corporation (XOMA)

Before we jump into XOMA Royalty Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Want to learn more about XOMA Royalty Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about XOMA Royalty Corporation.

XOMA Royalty Corporation’s Stock Price as of Market Close

As of December 09, 2025, 4:00 PM, CST, XOMA Royalty Corporation’s stock price was $32.080.

XOMA Royalty Corporation is up 5.21% from its previous closing price of $30.490.

During the last market session, XOMA Royalty Corporation’s stock traded between $31.360 and $34.250. Currently, there are approximately 12.14 million shares outstanding for XOMA Royalty Corporation.

XOMA Royalty Corporation’s price-earnings (P/E) ratio is currently at 37.1, which is high compared to the Biotechnology industry median of 19.9. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

XOMA Royalty Corporation Stock Price History

XOMA Royalty Corporation’s (XOMA) price is currently down 0.16% so far this month.

During the month of December, XOMA Royalty Corporation’s stock price has reached a high of $34.250 and a low of $29.065.

Over the last year, XOMA Royalty Corporation has hit prices as high as $39.920 and as low as $18.352. Year to date, XOMA Royalty Corporation’s stock is up 22.07%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused XOMA Royalty Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 09, 2025, there were analysts who downgraded XOMA Royalty Corporation’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate XOMA Royalty Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on XOMA Royalty Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

XOMA Royalty Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about XOMA Royalty Corporation (XOMA) by visiting AAII Stock Evaluator.

Relative Price Strength of XOMA Royalty Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 09, 2025, XOMA Royalty Corporation has a weighted four-quarter relative price strength of -3.80%, which translates to a Momentum Score of 44 and is considered to be Average.

Want to learn more about how XOMA Royalty Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

XOMA Royalty Corporation Stock Price: Bottom Line

As of December 9, 2025, XOMA Royalty Corporation’s stock price is $32.080, which is up 5.21% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like XOMA Royalty Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.